Takehiko Doi
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Thalidomide for CGD-related inflammatory bowel disease: A randomized, double-blind trial

Toshinao Kawai, Mayumi Sako, Katsuhiro Arai, Takashi Ishikawa, Tomoko Toma, Taizo Wada, Yutaro Yada, Masataka Ishimura, Takehiko Doi, Satoshi Okada, Hiroshi Moritake, Kazushi Izawa, Masahiro Ueki, Eisuke Inoue, Hidefumi Nakamura, Masafumi Onodera
Journal: Journal of Human Immunity
J Hum Immun (2026) 2 (5): e20250256.
https://doi.org/10.70962/jhi.20250256
Published: 23 June 2026
View article titled, Thalidomide for CGD-related inflammatory bowel disease: A randomized, double-blind trial
Open the PDF for Thalidomide for CGD-related inflammatory bowel disease: A randomized, double-blind trial in another window
Includes: Supplementary data
Journal Articles

Successful Sirolimus Therapy in Steroid-Refractory RAS-Associated Autoimmune Lymphoproliferative Disorder with Mosaic KRAS Mutation

Ryota Komori, Takaki Asano, Fumiaki Sakura, Takehiko Doi, Akifumi Endo, Kohsuke Imai, Satoshi Okada
Journal: Journal of Human Immunity
Series: JSIAD Meeting Abstracts 2026
J Hum Immun (2026) 2 (JSIAD2026): eJSIAD2026abstract.40.
https://doi.org/10.70962/JSIAD2026abstract.40
Published: 04 June 2026
View article titled, Successful Sirolimus Therapy in Steroid-Refractory RAS-Associated Autoimmune Lymphoproliferative Disorder with Mosaic KRAS Mutation
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal